Abstract:The intestine harbors a large population of microorganisms that interact with epithelial cells to maintain host healthy physiological status. These intestinal microbiota engage in the fermentation of non-digestible nutrients and produce beneficial metabolites to regulate host homeostasis, metabolism, and immune response. The disruption of microbiota, known as dysbiosis, has been implicated in many intestinal diseases, including colorectal cancer (CRC). As the third most common cancer and the second leading cause of cancer-related death worldwide, CRC poses a significant health burden. There is an urgent need for novel interventions to reduce CRC incidence and improve clinical outcomes. Modulating the intestinal microbiota has emerged as a promising approach for CRC prevention and treatment. Current research efforts in CRC probiotics primarily focus on reducing the incidence of CRC, alleviating treatment-related side effects, and potentiating the efficacy of anticancer therapy, which is the key to successful translation to clinical practice. This paper aims to review the traditional probiotics and new interventions, such as next-generation probiotics and postbiotics, in the context of CRC. The underlying mechanisms of probiotic anti-cancer effects are also discussed, including the restoration of microbial composition, reinforcement of gut barrier integrity, induction of cancer cell apoptosis, inactivation of carcinogens, and modulation of host immune response. This paper further evaluates the novel strategy of probiotics as an adjuvant therapy in boosting the efficacy of chemotherapy and immunotherapy. Despite all the promising findings presented in studies, the evaluation of potential risks, optimization of delivery methods, and consideration of intra-patient variability of gut microbial baseline must be thoroughly interpreted before bench-to-bedside translation.

Research Progress on the Improvement Effect and Mechanism of Probiotics on Colorectal Cancer

Research Progress of Probiotics in Colon Cancer Prevention and Its Molecular Mechanism

Research progress on the correlation between intestinal flora and colorectal cancer

The Protective Role of Probiotics against Colorectal Cancer

Correlation of Pathogenesis, Early Diagnosis and Treatment of Colorectal Cancer with Microorganisms

Mechanism of probiotics in the intervention of colorectal cancer: a review

Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer

Probiotics and the Role of Dietary Substrates in Maintaining the Gut Health: Use of Live Microbes and Their Products for Anticancer Effects against Colorectal Cancer

Research Progress in Probiotics in Cancer Prevention and Potential Mechanisms

The beneficial role of probiotics in colorectal cancer development and their prospects for application

Gut bacteria and colorectal cancer: from pathogens to therapeutics

Postbiotics in colorectal cancer: intervention mechanisms and perspectives

Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies

Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer

Exploiting lactic acid bacteria for colorectal cancer: a recent update

Colorectal cancer and gut microbiota studies in China

Preliminary study on the active substances and cellular pathways of lactic acid bacteria for colorectal cancer treatment

Beneficial insights into postbiotics against colorectal cancer

Relationship Between Ruminococcus and Colorectal Cancer and Its Anti-Cancer Mechanism

Intake of Pro- and/or Prebiotics as a Promising Approach for Prevention and Treatment of Colorectal Cancer

Research Progress on the Inhibitory Effects of Probiotics on N-nitroso Compound-induced Colon Carcinoma